NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









KisoJi Biotechnology

KisoJi Biotechnology

Private
MontrealHealthcare & Life Scienceshttps://www.kisojibiotech.com/

Last Round

Series B

Oct 1, 2024

Total Funding Raised

$41M

Company Overview

KisoJi Biotechnology is a biotechnology company that develops multi-specific antibody therapeutics for oncology and inflammatory diseases using a proprietary AI-enabled discovery platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

antibody discoverymulti-specific antibodiesdrug discoveryAI drug discoveryAI-driven drug discoveryepitope mappingtransgenic mouse modelsoncology therapeuticsbiotech R&Dtherapeutic antibodiesin silico drug designAI-enabled biotechantibody engineeringprecision medicineclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KisoJi Biotechnology Comparables

Compare KisoJi Biotechnology with similar companies based on industry and business-model similarity.

KisoJi Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AlivaMab Biologics
81%
OmniAb Inc.
80%
AbTherx, Inc.
80%

KisoJi Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 1, 2024

Key People

Founding team and executive leadership

David Young

CEO

Executive Team

KisoJi Biotechnology Investors

Notable investors and investment history

KisoJi Biotechnology investors
InvestorRounds
Investissement QuébecSeries B
Fonds de solidarité FTQSeries B
Remiges VenturesSeries A Extension, Series B
BDC CapitalSeries A Extension
Lumira VenturesSeries B
adMare BioInnovationsSeries B

KisoJi Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

KisoJi Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KisoJi Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal
Employee Range16
Year Founded2016
Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.